The predictive value of HER2DX assay with pathological response and prognosis in patients with early HER2-positive breast cancers: commentary on the PHERGain trial
@article{TCR97980, author = {Tasuku Matsuoka and Yurie Yamamoto and Masakazu Yashiro}, title = {The predictive value of HER2DX assay with pathological response and prognosis in patients with early HER2-positive breast cancers: commentary on the PHERGain trial}, journal = {Translational Cancer Research}, volume = {14}, number = {3}, year = {2025}, keywords = {}, abstract = {}, issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/97980} }